Interactions between insulin-like growth factor-I (IGF-I) and the renin- angiotensin system in follicular growth and ovulation

Yasunori Yoshimura, Nobumitsu Aoki, Kou Sueoka, Toyohiko Miyazaki, Naoaki Kuji, Mamoru Tanaka, Toshifumi Kobayashi

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The interactions between insulin-like growth factor-I (IGF-I) and the renin-angiotensin system (RAS) in follicular growth and ovulation were studied with the use of an isolated perfused rabbit ovary preparation. Ovulation failed to occur in either control ovaries or the experimental ovaries perfused with IGF-I in a concentration of 1, 10, or 100 ng/ml in the absence of gonadotropin. Exposure to IGF-I stimulated the secretion rate of angiotensin II-like immunoreactivity (Ang II-IR) in perfused rabbit ovaries in a dose-dependent manner. The percent increase in follicle diameter in ovaries perfused with IGF-I for 12 h was significantly correlated with the secretion rate of Ang II-IR at 12 h after exposure to IGF-I. The addition of IGFBP-3 to the perfusate did not induce ovulation in the absence of gonadotropin, but exposure to IGFBP-3 inhibited hCG-induced ovulation in a dose-dependent manner. In addition, IGFBP-3 significantly reduced the ovarian secretion rate of Ang II-IR and prostaglandins stimulated by hCG administration. Intrafollicular plasminogen activator (PA) activity significantly increased within 4 h after exposure to 100 ng/ml of IGF-I, compared with that in control ovaries perfused with medium alone. The concomitant addition of IGFBP-3 to the perfusate significantly reduced the IGF-I-stimulated PA activity in the preovulatory follicles at 4, 6, and 8 h after exposure to IGF-I. However, IGFBP-3 alone affected neither the ovarian secretion rate of Ang II-IR nor intrafollicular PA activity. Exposure to streptokinase, an exogenous PA, in vitro stimulated both follicular growth and the intrafollicular Ang II-IR content. In conclusion, IGF-I enhances both ovarian Ang II production and follicular development by stimulating intrafollicular PA activity.

Original languageEnglish
Pages (from-to)308-316
Number of pages9
JournalJournal of Clinical Investigation
Volume98
Issue number2
Publication statusPublished - 1996 Jul 15

Fingerprint

Renin-Angiotensin System
Ovulation
Insulin-Like Growth Factor I
Insulin-Like Growth Factor Binding Protein 3
Plasminogen Activators
Ovary
Angiotensin II
Growth
Gonadotropins
Rabbits
Streptokinase
Prostaglandins

Keywords

  • angiotensin II
  • follicular growth
  • insulin-like growth factor binding protein
  • insulin-like growth factor-I
  • plasminogen activator activity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Interactions between insulin-like growth factor-I (IGF-I) and the renin- angiotensin system in follicular growth and ovulation. / Yoshimura, Yasunori; Aoki, Nobumitsu; Sueoka, Kou; Miyazaki, Toyohiko; Kuji, Naoaki; Tanaka, Mamoru; Kobayashi, Toshifumi.

In: Journal of Clinical Investigation, Vol. 98, No. 2, 15.07.1996, p. 308-316.

Research output: Contribution to journalArticle

Yoshimura, Yasunori ; Aoki, Nobumitsu ; Sueoka, Kou ; Miyazaki, Toyohiko ; Kuji, Naoaki ; Tanaka, Mamoru ; Kobayashi, Toshifumi. / Interactions between insulin-like growth factor-I (IGF-I) and the renin- angiotensin system in follicular growth and ovulation. In: Journal of Clinical Investigation. 1996 ; Vol. 98, No. 2. pp. 308-316.
@article{b7ee0b4301874eb0baf9628bba484eab,
title = "Interactions between insulin-like growth factor-I (IGF-I) and the renin- angiotensin system in follicular growth and ovulation",
abstract = "The interactions between insulin-like growth factor-I (IGF-I) and the renin-angiotensin system (RAS) in follicular growth and ovulation were studied with the use of an isolated perfused rabbit ovary preparation. Ovulation failed to occur in either control ovaries or the experimental ovaries perfused with IGF-I in a concentration of 1, 10, or 100 ng/ml in the absence of gonadotropin. Exposure to IGF-I stimulated the secretion rate of angiotensin II-like immunoreactivity (Ang II-IR) in perfused rabbit ovaries in a dose-dependent manner. The percent increase in follicle diameter in ovaries perfused with IGF-I for 12 h was significantly correlated with the secretion rate of Ang II-IR at 12 h after exposure to IGF-I. The addition of IGFBP-3 to the perfusate did not induce ovulation in the absence of gonadotropin, but exposure to IGFBP-3 inhibited hCG-induced ovulation in a dose-dependent manner. In addition, IGFBP-3 significantly reduced the ovarian secretion rate of Ang II-IR and prostaglandins stimulated by hCG administration. Intrafollicular plasminogen activator (PA) activity significantly increased within 4 h after exposure to 100 ng/ml of IGF-I, compared with that in control ovaries perfused with medium alone. The concomitant addition of IGFBP-3 to the perfusate significantly reduced the IGF-I-stimulated PA activity in the preovulatory follicles at 4, 6, and 8 h after exposure to IGF-I. However, IGFBP-3 alone affected neither the ovarian secretion rate of Ang II-IR nor intrafollicular PA activity. Exposure to streptokinase, an exogenous PA, in vitro stimulated both follicular growth and the intrafollicular Ang II-IR content. In conclusion, IGF-I enhances both ovarian Ang II production and follicular development by stimulating intrafollicular PA activity.",
keywords = "angiotensin II, follicular growth, insulin-like growth factor binding protein, insulin-like growth factor-I, plasminogen activator activity",
author = "Yasunori Yoshimura and Nobumitsu Aoki and Kou Sueoka and Toyohiko Miyazaki and Naoaki Kuji and Mamoru Tanaka and Toshifumi Kobayashi",
year = "1996",
month = "7",
day = "15",
language = "English",
volume = "98",
pages = "308--316",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Interactions between insulin-like growth factor-I (IGF-I) and the renin- angiotensin system in follicular growth and ovulation

AU - Yoshimura, Yasunori

AU - Aoki, Nobumitsu

AU - Sueoka, Kou

AU - Miyazaki, Toyohiko

AU - Kuji, Naoaki

AU - Tanaka, Mamoru

AU - Kobayashi, Toshifumi

PY - 1996/7/15

Y1 - 1996/7/15

N2 - The interactions between insulin-like growth factor-I (IGF-I) and the renin-angiotensin system (RAS) in follicular growth and ovulation were studied with the use of an isolated perfused rabbit ovary preparation. Ovulation failed to occur in either control ovaries or the experimental ovaries perfused with IGF-I in a concentration of 1, 10, or 100 ng/ml in the absence of gonadotropin. Exposure to IGF-I stimulated the secretion rate of angiotensin II-like immunoreactivity (Ang II-IR) in perfused rabbit ovaries in a dose-dependent manner. The percent increase in follicle diameter in ovaries perfused with IGF-I for 12 h was significantly correlated with the secretion rate of Ang II-IR at 12 h after exposure to IGF-I. The addition of IGFBP-3 to the perfusate did not induce ovulation in the absence of gonadotropin, but exposure to IGFBP-3 inhibited hCG-induced ovulation in a dose-dependent manner. In addition, IGFBP-3 significantly reduced the ovarian secretion rate of Ang II-IR and prostaglandins stimulated by hCG administration. Intrafollicular plasminogen activator (PA) activity significantly increased within 4 h after exposure to 100 ng/ml of IGF-I, compared with that in control ovaries perfused with medium alone. The concomitant addition of IGFBP-3 to the perfusate significantly reduced the IGF-I-stimulated PA activity in the preovulatory follicles at 4, 6, and 8 h after exposure to IGF-I. However, IGFBP-3 alone affected neither the ovarian secretion rate of Ang II-IR nor intrafollicular PA activity. Exposure to streptokinase, an exogenous PA, in vitro stimulated both follicular growth and the intrafollicular Ang II-IR content. In conclusion, IGF-I enhances both ovarian Ang II production and follicular development by stimulating intrafollicular PA activity.

AB - The interactions between insulin-like growth factor-I (IGF-I) and the renin-angiotensin system (RAS) in follicular growth and ovulation were studied with the use of an isolated perfused rabbit ovary preparation. Ovulation failed to occur in either control ovaries or the experimental ovaries perfused with IGF-I in a concentration of 1, 10, or 100 ng/ml in the absence of gonadotropin. Exposure to IGF-I stimulated the secretion rate of angiotensin II-like immunoreactivity (Ang II-IR) in perfused rabbit ovaries in a dose-dependent manner. The percent increase in follicle diameter in ovaries perfused with IGF-I for 12 h was significantly correlated with the secretion rate of Ang II-IR at 12 h after exposure to IGF-I. The addition of IGFBP-3 to the perfusate did not induce ovulation in the absence of gonadotropin, but exposure to IGFBP-3 inhibited hCG-induced ovulation in a dose-dependent manner. In addition, IGFBP-3 significantly reduced the ovarian secretion rate of Ang II-IR and prostaglandins stimulated by hCG administration. Intrafollicular plasminogen activator (PA) activity significantly increased within 4 h after exposure to 100 ng/ml of IGF-I, compared with that in control ovaries perfused with medium alone. The concomitant addition of IGFBP-3 to the perfusate significantly reduced the IGF-I-stimulated PA activity in the preovulatory follicles at 4, 6, and 8 h after exposure to IGF-I. However, IGFBP-3 alone affected neither the ovarian secretion rate of Ang II-IR nor intrafollicular PA activity. Exposure to streptokinase, an exogenous PA, in vitro stimulated both follicular growth and the intrafollicular Ang II-IR content. In conclusion, IGF-I enhances both ovarian Ang II production and follicular development by stimulating intrafollicular PA activity.

KW - angiotensin II

KW - follicular growth

KW - insulin-like growth factor binding protein

KW - insulin-like growth factor-I

KW - plasminogen activator activity

UR - http://www.scopus.com/inward/record.url?scp=0030016996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030016996&partnerID=8YFLogxK

M3 - Article

C2 - 8755639

AN - SCOPUS:0030016996

VL - 98

SP - 308

EP - 316

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -